Merck Discontinues Bacterial Infection Drug in Europe
Merck withdraws bacterial infection drug Zinplava in the EU and after the December 2024 US market exit for commercial reasons.
Share
Why It Matters
Merck is stopping sales of an infection medicine in Europe and the US. When a company stops selling a drug, watch whether they have other products to replace that sales money.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.